Students of the year 2008


  1. Andrea Autengruber AUSTRIA
    supervisor: Dr. Bruder, HZI Braunschweig,
    project:  Characterization and manipulation of type II alveolar epithelial cell function in T cell mediated pulmonary inflammation
    Final exam June 2012; Leibniz-Institute for environment-medical research (IUF), Particle-Cell-Interaction, Düsseldorf; Senior Clinical Research Associate (CRA), Regional Medical Advisor / MSL (Pneumology), GlaxoSmithKline GSK (residing in Braunschweig)

  2. Kiran Peddireddi (nee Bala) INDIA
    supervisor: Prof. Dr Schulz, Virology, OE 5230,   
    project:  Development of an animal model to test the in-vivo function of the Kaposi Sarcoma Herpes Virus K15 protein
    Final exam November 2012; clinical data manager at MRC clinical trials unit at University College (UCL), London, UK

  3. Rajkumar Bhayadia INDIA
    supervisor: Dr. Melk, Pediatric Nephrology, OE 6720,    
    project: The role of endothelial cellular senescence in endothelial dysfunction and cardiovascular disease
    Final exam June 2014. Pediatric Hematology, MHH; now Leukemia research, Martin-Luther University, Halle

  4. Krishna Chaitanya Vallabhaneni INDIA 
    supervisor: Prof. Dr. Dumler, Nephrology, OE 6840,     
    project:  Role of Urokinase receptor in mobilization and differentiation of mesenchymal stem cells: impact on blood vessel repair after vascular injury and organ transplantation
    Final exam June 2012; Dec 2012 - April 2016 Postdoc Cancer Institute, UMMC, Jackson, Mississippi; May 2016- June 2017 Faculty member of Radiation Oncology, Department of Medicine, UMMC, Jackson, Mississippi, USA. From July 2017 Field Application Scientist for South East Territory at Nexcelom Bioscience, Raleigh-Durham, North Carolina, USA; since April 2019 Field Applications Scientists for Mid Atlantic and South East territory at Maxcyte Inc.

  5. Tamaryin Godinho PORTUGAL 
    supervisor: Prof. Dr. Baum, Experimental Hematology and Oncology, OE 6960,
    project: Cell fate modification by reversible expression of signalling proteins
    Final exam June 2013; Experimental Haematology, MHH; now associate Editor - Angewandte Chemie, Wiley-VCH, Weinheim

  6. Dirk Heckl GERMANY   
    supervisor: Prof. Dr. Baum, Experimental Hematology, OE 6960,    
    project: Correction of MPL deficiency by gene transfer
    Final exam June 2011; Harvard Medical School, USA; Pediatric Hematology, MHH (group leader); now W2 professor for Experimental Pediatrics at the Martin-Luther University of Halle

  7. Yarua Jaimes VENEZUELA
    supervisor: Prof. Dr. Blasczyk, Transfusion Medicine, OE 8350,  
    project: Decreasing the immunogenicity of cell based therapeutics by regulating the expression of HLA class II and adhesion molecules 
    Final exam November 2011; Immune Regulation, Deutsches Rheuma-Forschungzentrum (DRFZ), Berlin; since 2013 Fraunhofer institute for cell therapies and Immunology (Fraunhofer IZI) in Leipzig, since 2017 group leader

  8. Daniela Prochaska (nee Kieneke) GERMANY 
    supervisor: Prof. Dr. Sodeik, Virology, OE 5230;
    project: Biochemical Characterization of the recruitment of host factors such as microtubule motors and importins to the capsid of Herpes-Simplex-Virus
    Final exam June 2012; from 2013 Immungenetics (among head of lab), Transfusion Medicine, MHH; Manager Vaccine Production/Associate Director Operations at Burgwedel Biotech GmbH/ MSD Animal Health; since 2019 professor, Technical Biochemistry and Pharmacology, Hochschule für Angewandte Wissenschaften, Hamburg

  9. Annika Krämer-Kühl GERMANY
    supervisor: Prof. Dr. Behrens/ Pof. Dr. Pöhlmann, Clinical Immunology and Rheumatology, OE 6830,  
    project: Tetherin and Vpu: Molecular studies and clinical relevance of a new potential therapeutic target in HIV-infection
    Final exam November 2011; Infection Biology, German Primate Center, DPZ, Göttingen; from February 2013 R&D Boehringer Ingelheim Veterinary Research Center Hannover; from July 2019 Study Manager Clinical Operations, Roche, Mannheim

  10. Elena Lam GERMANY  
    supervisor:  Prof. Dr. Heim, Virology, OE 5230,    
    project: Virulence factors of pneumotropic adenovirus types
    Final exam November 2011; Molecular Virology, Heinrich Pette Institute, Hamburg; from 2016 Process Engineer, IDT-Biologika, Dessau-Rosslau

  11. Hui Zhi Low SINGAPORE 
    supervisor: Prof. Dr. Witte, Clinical Immunology and Rheumatology, OE 6830,
    project:  Investigation into the role of ILT6 in immunomodulation and in autoimmune diseases and cancer
    Final exam June 2012; Clinic for Immunology and Rheumatology, MHH; now Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine, Hannover

  12. Aliaksandra Maroz BELARUS 
    supervisor: Dr. Klusmann, Pediatric Hematology and Oncology, OE 6780,  
    project: Molecular mechanism of GATA1s-mediated malignant transformation of fetal hematopoietic stem and progenitor cells 
    Final exam November 2012; from 2013 Scientific Manager at Sysmex Europe GmbH, Hamburg; obtained an MBA degree from the Frankfurt School of Finance and Management in 2017; from 2018 Business Development Manager at Sysmex Europe; from May 2019 Specialist Global Business Intelligence and Development, Eppendorf AG, Hamburg

  13. Martin May GERMANY  
    supervisor: Dr. Genth, Toxicology, OE 5340,
    project: Consequences of cytokinesis inhibition by bacterial toxins
    Final exam November 2011; Toxicology MHH,  Fraunhofer Institute ITEM Hannover, now Manager Scientific Affairs, BODE Chemie GmbH, Hamburg

  14. Vanessa Melhorn GERMANY 
    supervisor: Dr. Bohne, Virology, OE 5230,
    project: Regulation of retroviral RNA export: an interplay of quality control and processing signals
    Final exam June 2012; Virology MHH, coordinator of SFB; from 2017 scientific project manager for TI Epidemiology in DZIF, HZI Braunschweig

  15. Pooja Mishra INDIA  
    supervisor: Prof. Dr. Förster, Immunology, OE 5240,  
    project:  The spatio-temporal distribution of regulatory T cells during chronic organ rejection
    Final exam June 2012; from 09/13 Canada, Vancouver (at Stemcell Technologies as Program Associate); from 2016 Program manager, Stemcell technologies Inc., Vancouver, Canada

  16. Dhaarini Murugan INDIA
    superrvisor: Prof. Dr. Klein, Pediatric Hemnatology and Oncology, OE 6780,    
    project: Investigation of the functional role of IL10R2 in the hematopoietic system and the deficient state being a potential cause of immune disorder in Inflammatory Bowel Disease
    Final exam November 2013. Pediatrics, University Hospital Munich; now Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, USA

  17. Nils Pfaff GERMANY 
    supervisor: Prof. Dr. Moritz, REBIRTH, OE 8880,
    project: Generation of induced pluripotent stem cells with hematopoietic origin
    Final exam November 2011; REBIRTH MHH; from 2013 lab head Cardiogenomics, Bayer HealthCare, Wuppertal

  18. Tim Ripperger  ( GERMANY 
    supervisor: Prof. Dr. Schlegelberger, Cell-/ Molecular Pathology, OE 5120,
    project: Investigation of the ETS-transcription factor GABP
    Final exam June 2013; Cell and Molecular Pathology (now Human genetics), MHH

  19. Volker Rust GERMANY
    supervisor: Dr. B. Wölk, Virology, OE 5230,  
    project: Cellular factors governing hepatitis C virus replication complex formation and trafficking
    Final exam November 2012; representative, Almirall Hermal, Reinbek (Hamburg); from 2015 Account Manager at Roche Diagnostics Deutschland; Marketing- und Produkt Manager Labordiagnostik, Roche Diagnostics Deutschland GmbH, Mannheim

  20. Ayesha Sultan INDIA 
    supervisor: Prof. Dr. Seidler, Gastroenterology/Hepatology/Endocrinology, OE 6810,   
    project: Unterstanding the molecular mechanisms for intestinal transport dysfunction in cystic fibrosis – role of PDZ adapter proteins and changes in signalling
    Final exam June 2012; Institute of Physiology, University of Ulm; Postdoc in Boston, USA; maternity; now reintegration to research